J&J: Booster dose of its COVID shot prompts strong response
Team Udayavani, Sep 21, 2021, 5:44 PM IST
Johnson & Johnson released data showing that a booster dose to its one-shot coronavirus vaccine provides a strong immune response months after people receive a first dose.
J&J said in statement Tuesday that it ran two early studies in people previously given its vaccine and found that a second dose produced an increased antibody response in adults from age 18 to 55.
The study’s results haven’t yet been peer-reviewed.
“A booster dose of the Johnson & Johnson COVID-19 vaccine further increases antibody responses among study participants who had previously received our vaccine,” said Dr. Mathai Mammen, global head of research and development at J&J.
The company is in talks with regulators including the US Food and Drug Administration, the European Medicines Agency and others regarding using booster doses of its vaccine.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Biden administration official backs reform of UN in response to Musk’s comments on permanent UNSC seat for India
Russia initiates withdrawal of peacekeeping forces from Karabakh as Azerbaijan takes full control of the region
Unprecedented rainfall in Dubai: Social media flooded with visuals of submerged airport & streets
Israel’s Defense Innovations: From Iron Dome to Arrow 3
Heavy rains set off flash floods killing 33 people in Afghanistan
MUST WATCH
Latest Additions
Injuries don’t define you: Mohammed Shami shares rehab update
Shivakumar desperately wants to become CM, says K’taka BJP chief Vijayendra
Scribe throws lapel microphone towards Sharad Pawar in Baramati; cops give clean chit
India delivers first batch of BrahMos missiles to Philippines
Air India cancels Dubai flights due to operational disruptions